Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra.
Colina
Matteo
M
Pizzirani
Cinzia
C
Khodeir
Micheline
M
Falzoni
Simonetta
S
Bruschi
Marco
M
Trotta
Francesco
F
Di Virgilio
Francesco
F
D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008875:Middle Aged; D058486:Receptors, Purinergic P2X7 / Q000378:metabolism*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D058486:Receptors, Purinergic P2X7